Prelude Capital Management’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,000
Closed -$97K 1963
2022
Q1
$97K Hold
10,000
﹤0.01% 1136
2021
Q4
$97K Hold
10,000
﹤0.01% 1361
2021
Q3
$97K Hold
10,000
﹤0.01% 1160
2021
Q2
$97K Buy
+10,000
New +$97K ﹤0.01% 1201